KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Other Non-Current Liabilities (2019 - 2025)

Adaptive Biotechnologies' Other Non-Current Liabilities history spans 6 years, with the latest figure at $20000.0 for Q4 2025.

  • For Q4 2025, Other Non-Current Liabilities changed 0.0% year-over-year to $20000.0; the TTM value through Dec 2025 reached $20000.0, changed 0.0%, while the annual FY2025 figure was $20000.0, 0.0% changed from the prior year.
  • Other Non-Current Liabilities for Q4 2025 was $20000.0 at Adaptive Biotechnologies, roughly flat from $20000.0 in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $128.2 million in Q2 2023 and bottomed at $20000.0 in Q2 2024.
  • The 4-year median for Other Non-Current Liabilities is $20000.0 (2024), against an average of $45.9 million.
  • The largest annual shift saw Other Non-Current Liabilities tumbled 99.98% in 2024 before it changed 0.0% in 2025.
  • A 4-year view of Other Non-Current Liabilities shows it stood at $125.4 million in 2022, then rose by 2.24% to $128.2 million in 2023, then crashed by 99.98% to $20000.0 in 2024, then changed by 0.0% to $20000.0 in 2025.
  • Per Business Quant, the three most recent readings for ADPT's Other Non-Current Liabilities are $20000.0 (Q4 2025), $20000.0 (Q3 2025), and $20000.0 (Q2 2025).